Last Updated: November 3, 2026
Quick Summary
Buying cagrilintide research material in the UK rests on checking documentation before you order. Look for a batch-specific Certificate of Analysis that names the purity method, confirms identity by mass spectrometry, and states the testing laboratory. Keep the CoA with your laboratory records to maintain traceability.
- Confirm the batch number on the Certificate of Analysis matches the number printed on the vial label.
- Ask for the analytical method behind the purity figure, typically HPLC, before ordering.
- Identity should be confirmed by mass spectrometry, with observed mass compared against theoretical mass.
- Treat a specification range such as 95 per cent or above as a supplier threshold, not a measured result.
- Check current MHRA guidance on medicines before purchasing, as research-use-only labelling does not make any other use lawful.
Table of Contents
- Research Use Only: Regulatory Status and Legal Boundaries in the UK
- Reading a Cagrilintide Certificate of Analysis
- How to Verify Research Peptide Purity Before You Commit
- Research Peptide Supplier Checklist for UK Laboratories
- Vial Sizes, Storage and Handling of Cagrilintide
- Placing Your Next Cagrilintide Order With Confidence
- Frequently Asked Questions
Buying Cagrilintide for cagrilintide research is a process that rewards careful checking. The compound is a long-acting amylin analogue studied in laboratory and preclinical settings, and the purchase decision rests on documentation, traceability and honest supplier practice. This guide from Research Peptides and Laboratory Products sets out what UK research buyers should check before they order.
Cagrilintide is a synthetic amylin analogue. Amylin is a hormone co-secreted with insulin, and researchers study analogues of it because of its role in appetite and bodyweight regulation. The long-acting design is the feature that drew attention in the research literature, since it allows study of sustained receptor activity.
Most published work on cagrilintide research sits in preclinical and clinical trial literature. Clinical findings are informative, but they describe defined trial conditions and do not automatically transfer to a research vial bought from a supplier. A researcher planning a study should treat published evidence and product documentation as two separate questions.
Keep in mind that cagrilintide is a research peptide. It is not an approved medicine for general sale, and this guide does not describe any human use or dosing.
Research Use Only: Regulatory Status and Legal Boundaries in the UK
Cagrilintide is supplied for laboratory research use only. Buyers should understand the regulatory position in the United Kingdom before placing an order, because the rules on medicines, supply and intended use shape what a supplier can lawfully sell and what a purchaser can lawfully do with it. Check current guidance from the Medicines and Healthcare products Regulatory Agency guidance on medicines before purchasing.
Research-use-only labelling does not, on its own, make a product lawful for any other purpose. Any use outside a properly governed laboratory setting falls outside what this guide covers, and it is the buyer’s responsibility to confirm their own institutional and legal obligations.
Reading a Cagrilintide Certificate of Analysis
A Certificate of Analysis (CoA) is the document that ties a vial to its tested properties, and reading one properly is a skill rather than a formality. The useful question is what a good CoA actually says. A CoA worth relying on names the batch number, identifies the material by name and any internal catalogue reference, states the purity result together with the analytical method used to obtain it, confirms identity with supporting data, and gives the quantity with a clear measurement basis.
Start with the batch number. A practical guide to batch traceability, identity, purity and quantity documentation sets out what each section of a cagrilintide CoA should show. It should match the number printed on the vial label exactly. A CoA that covers a product line rather than a specific lot tells you nothing about the material in your hand, because purity and identity vary between batches even when the synthesis route is unchanged. If the batch numbers do not match, treat the documentation as unreliable until the supplier explains the discrepancy in writing.
Next, read the purity result alongside its method. High-performance liquid chromatography (HPLC) is the standard technique for reporting peptide purity, and the result is usually expressed as a percentage of the total chromatographic peak area. A figure such as 98 per cent means the main peak accounts for that share of the detected signal, it does not mean the vial is 98 per cent pure in every conceivable sense, and it says nothing about residual solvents, counter-ions or endotoxin unless those are separately reported. Check whether the CoA states the column, detection wavelength and gradient, or at least the method reference, because a purity figure without a method cannot be assessed.
Identity is a separate question from purity. Mass spectrometry (MS) is the common confirmation technique, and a useful CoA reports the observed mass against the theoretical mass for the expected molecular formula, often as an m/z value for the relevant charge state. A purity figure alone cannot tell you that the main peak is cagrilintide rather than a closely related analogue or a synthesis by-product, which is why identity data matter. Where an assay or content determination is reported, look for the method and the units, because a stated vial content without a measurement basis tells you little.
Watch out: a CoA that reports a purity percentage with no method, no identity data and no batch number is a marketing document rather than an analytical record, and it should not be treated as evidence of quality.
Finally, check the testing laboratory. A CoA issued by an independent analytical laboratory, with the laboratory named and a report reference you can trace, carries more weight than an in-house sheet with no provenance. Batch-specific documentation supports traceability, allowing a later experimental result to be linked back to a particular lot. Keep the CoA with your laboratory records so the chain from vial to result stays intact.
The table below sets out the four things a good certificate should show, and the warning sign to watch for in each.
| Check | What to look for | Warning sign |
|---|---|---|
| Batch number | Matches the number on the vial label | Covers a product line, not a specific lot |
| Purity | Percentage stated with its analytical method | Figure given with no method named |
| Identity | Observed mass against theoretical mass | No identity data reported |
| Testing laboratory | Named, with a traceable report reference | In-house sheet with no provenance |
How to Verify Research Peptide Purity Before You Commit
Purity claims are only as good as the method behind them, and verification is a process rather than a single check. High-performance liquid chromatography is the common technique for reporting peptide purity, and mass spectrometry is commonly used to confirm identity. A supplier that reports purity without naming the method, or that reports identity without any supporting data, has not given you enough to verify the product. The practical question is how to test those claims before money changes hands.
Work through four checks in order. First, ask for the batch-specific CoA before ordering, not after delivery, and confirm the batch number it covers. Second, confirm the analytical method is named for both purity and identity, HPLC for purity and MS for identity is the usual pairing, and that the CoA reports the actual result rather than a specification range alone. Third, establish whether the testing was carried out by an independent laboratory or in-house, and ask for the laboratory name and report reference if independence is claimed. Fourth, check that the quantity basis is stated, because a vial label that says 10mg without a content determination method is a claim rather than a measurement.
A common pattern among weaker suppliers is to publish a generic certificate for a product line and describe testing as “third-party” without naming the laboratory or providing a traceable reference. Independent analytical verification is worth looking for, and it should be stated clearly rather than implied. If a supplier cannot or will not name the testing laboratory, treat the independence claim as unverified.
Watch out: a certificate that shows a specification range such as “≥95 per cent” rather than the measured result for your batch tells you what the supplier will accept, not what the vial contains.
Where claims conflict, for example, a high purity figure alongside identity data that does not match the expected mass, do not average the two or assume the better figure is correct. Ask the supplier to explain the discrepancy in writing and hold the order until they do. A supplier that answers each point plainly, with named methods, named laboratories and traceable references, is easier to trust than one that relies on general quality statements. Record what you verified and when, so the check forms part of your procurement file alongside the CoA itself.
Research Peptide Supplier Checklist for UK Laboratories
Use this checklist when comparing suppliers:
- Batch-specific CoA provided with each order
- Analytical method named for purity and identity
- Independent testing described, not assumed
- Quantity basis stated clearly
- Clear research-use-only labelling
- Traceable batch numbers that match the vial
- Transparent sourcing and manufacturing information
- Documented storage and handling guidance
Suppliers vary widely in how much of this they disclose. A supplier that answers each point plainly is easier to trust than one that relies on general quality statements.
Procurement and Institutional Purchasing
Many research teams buy through institutional procurement. Before placing an order, confirm the payment methods and purchase-order processes the supplier accepts, and ask for any vendor documentation your procurement team requires.
Vial Sizes, Storage and Handling of Cagrilintide
Check the product listing for the current vial options, for example the Cagrilintide 10mg product on the Research Peptides and Laboratory Products website.
Storage affects stability. Follow the storage conditions stated on the product documentation, keep vials sealed until use, and record handling steps as part of your laboratory records. If documentation does not state storage conditions, ask the supplier before the material arrives.
Placing Your Next Cagrilintide Order With Confidence
Before you order, confirm that the batch documentation matches the product, that the analytical methods are named, and that the supplier’s delivery and payment process fits your institution. Pricing depends on quantity, dates and delivery, so check the product page or request a quote directly from Research Peptides and Laboratory Products for up-to-date pricing.
For research teams that need dependable, batch-traceable materials, a documented and independently verified supply is the sensible starting point. Explore the research collection at Research Peptides and Laboratory Products to compare the current range before you commit.
Frequently Asked Questions
Where can researchers source Cagrilintide for laboratory research?
Researchers in the UK typically source Cagrilintide from specialist suppliers of research-use-only materials. Before ordering, check that the supplier clearly labels products as sold for laboratory research, provides batch-specific documentation and states where stock is held. Pricing varies with quantity and delivery terms, so request a current quote from the supplier rather than relying on third-party figures. Compare the documentation offered, not just the headline cost, as this determines how well the material can be traced in your own records.
What documentation should accompany a Cagrilintide research peptide?
A batch-specific certificate of analysis is the core document. It should list the batch number, the identity method used, the purity result from a recognised analytical technique such as HPLC, and the date of testing. Check whether the testing was performed by an independent laboratory or by the supplier itself. Storage recommendations and a clear research-use-only statement should also be included. Keep these records with your experimental files so results can be traced back to the exact batch used.
How can researchers assess the quality and identity of Cagrilintide?
Quality assessment combines reviewing the supplier’s documentation with your own verification where facilities allow. Confirm that the identity test and purity figure on the certificate match the batch you received. Inspect the vial for labelling accuracy and any signs of damage. Where your laboratory has analytical capability, independent testing of identity and purity provides a stronger basis for reproducibility than documentation alone. Record any discrepancies and raise them with the supplier before use.
Is Cagrilintide sold for research the same as an approved medicine?
No. Cagrilintide is supplied as a research material and is not an approved medicine for human use in the UK. Products sold for research are intended for laboratory and analytical work only, and they are not subject to the same manufacturing, licensing and clinical oversight as licensed pharmaceuticals. Research findings from clinical trials of the compound are published separately and should be read with their own limitations in mind. Any use outside a controlled research protocol is outside the scope of this supply.
